CIF 2024
Celebrating Innovation
The CIF 2024 Awards
The California Investment Forum is not just an event; it's a prestigious platform where groundbreaking companies are recognized for leading the charge towards a sustainable and innovative future. Winning here means joining an elite circle of pioneers, gaining unparalleled exposure, and accessing a network of potential investors and partners dedicated to fostering cutting-edge solutions.
We offer a unique opportunity for ambitious companies to showcase their contributions to industry and society, connecting with global leaders and sparking meaningful collaborations. This recognition serves as a beacon, highlighting your company as a frontrunner in technological advancement and sustainable development.
Join us to celebrate your achievements, amplify your impact, and take your place among the leaders shaping our world. The California Investment Forum is where your innovation earns the spotlight it deserves.
CIF 2024 Award Winner:
Combustion Associates, Inc.
Category:
Green Energy Innovation
Website:
Company Description:
CAI provides custom engineering and manufacturing solutions to the Energy, Process and Environmental industries worldwide.
​
Factors Considered:
CAI’s consistent efforts to enhance its portfolio offerings to include generators that utilize 100% hydrogen fuel to produce clean power and contribute to the mitigation of environmental pollution and climate change.
.jpg)
CIF 2024 Award Winner:
NEONC TECHNOLOGIES HOLDINGS, INC.
Category:
Breakthrough Medical Technology (drug delivery method)
Website:
Company Description:
NEONC Technologies Holdings Inc. is a leading biotech company specializing in oncology, with a primary focus on brain cancer and central nervous system (CNS) diseases.
​
Factors Considered:
NEONC is pioneering novel approaches in oncology, including their focus on brain cancer and CNS diseases, as well as the development of a unique non-invasive nasal delivery system. This innovative technology, coupled with their impressive intellectual property portfolio of 135 patents, with 100 patents issued worldwide, has the potential to significantly impact the field of cancer treatment.
CIF 2024 Award Winner:
Helio Genonmics
Category:
AI based medical technology
Website:
Company Description:
Helio is an early cancer screening company. Their mission is to transform the paradigm of cancer screening by developing multi-analyte blood tests with greater sensitivity and specificity and ease-of-use compared to current screening modalities using AI technology.
​
Factors Considered:
HelioLiver, is a multi-analyte blood test that analyzes cell-free DNA, or cfDNA, methylation patterns, serum protein markers and demographic information with a simple blood draw to detect hepatocellular carcinoma, or HCC, the most common form of liver cancer.
CIF 2024 Award Winner:
Sparkz
Category:
Clean Transportation Innovation Award
Website:
Company Description:
Leading the manufacturing of materials for Lithium-ion batteries using all raw materials sourced domestically.
​
Factors Considered:
Pioneering the setting up of fully vertically integrated manufacturing of lithium-ion batteries from materials to cells to battery packs in California using all domestically sourced raw materials.
CIF 2024 Award Winner:
Breakthrough Genomics
Category:
Breakthrough Medical Technology in Diagnostics
Website:
Company Description:
Breakthrough Genomics is a leading company in the clinical interpretation of genomic data. They operate a CAP (College of American Pathologists) and CLIA (Clinical Laboratory Improvement Amendments)-certified genomics lab, providing advanced genetic tests for risk assessment, rare disease diagnosis, and early cancer detection. The company's mission is to enhance access to life-saving tests and precision medicine globally
​
Factors Considered:
They developed the most cutting-edge AI in diagnosing rare diseases and early-stage pancreatic cancer.
CIF 2024 Award Winner:
Advanced Prenatal Therapeutics
Category:
Breakthrough Medical Technology in diagnosis and Treatment
Website:
Company Description:
Advanced Prenatal Therapeutics, Inc. (APT) has received Breakthrough Medical Device Designation by the US FDA for its novel therapy in development to treat preeclampsia (PE), an unmet need and leading cause of maternal and fetal death worldwide.
​
Factors Considered:
APT's Targeted Apheresis Column for Preeclampsia holds promise to become the first medical device to specifically treat preeclampsia, an unmet medical need affecting 8% of pregnancies in the USA and up to 14% worldwide. APT's breakthrough medical device could become the standard of medical care for treating PE.
CIF 2024 Award Winner:
Lexibl
Category:
Education Technology Excellence Award
Website:
Company Description:
Lexibl is a cutting edge B2B SaaS solution that is redefining the way professionals engage with text. Inspired by people with reading challenges.
​
Factors Considered:
Lexibl currently customizes pdf texts in the desired format for each user including people with Dyslexia.
CIF 2024 Award Winner:
lucinetic
Category:
AI Pioneer Award (GEO AI for Business Intelligence)
Website:
Company Description:
Lucinetic is a pioneering company that focuses on integrating generative AI with location intelligence. Their platform enables analysts and decision-makers to query geospatial data using natural language, unlocking new high-value opportunities without requiring technical expertise.
​
Factors Considered:
Their mission is to use their AI technology to give 20 M businesses in the US the power of location intelligence by leveraging proprietary dynamical systems research and LLMs for search, generation and synthesis of complex geographic data, maps, imagery and spatial tasks.
Company Description:
Podopolo’s AI enables brands and businesses of all sizes to get a significantly larger return on their investment.
​
Factors Considered:
The company uses AI for the first time to open contextual advertising to 98% of podcasts that never before qualified.
It is an innovation uniquely provided to correlate deep behavioral and psychographic audience insights a with real time data.
California Investment Forum
© Copyright 2024. California Investment Forum. All Rights Reserved